Related Experiment Video

Updated: Aug 19, 2026

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Anemia and inflammation in COPD

Matthias John1, Soeren Hoernig, Wolfram Doehner

  • 1Department of Pneumology, University Hospital Charité, Campus Mitte, Schumannstr. 20/21, 10098 Berlin, Germany. matthias.john@charite.de

Chest
|March 15, 2005
PubMed

Insights

Anemia affects 13% of COPD patients, showing high erythropoietin levels and inflammation, suggesting erythropoietin resistance possibly due to chronic illness inflammation.

Area of Science:

  • Pulmonary Medicine
  • Hematology

Background:

  • Anemia in patients with Chronic Obstructive Pulmonary Disease (COPD) and its underlying pathophysiology remain understudied.
  • Understanding anemia in COPD is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of anemia in COPD patients.
  • To investigate the relationship between anemia and body mass, weight loss, inflammatory markers, and erythropoietin levels in COPD.
  • To identify factors influencing anemia development in COPD.

Main Methods:

  • A study involving 101 COPD patients (FEV1 37% +/- 2%) and a control group of age-matched healthy individuals.
  • Assessment of anemia prevalence, body mass, weight loss, inflammatory parameters, and erythropoietin levels.
  • Comparison of data between anemic and non-anemic COPD patients and the control group.

Main Results:

  • Anemia prevalence was 13% in the studied COPD population (hemoglobin < 13.5 mg/dL for males, < 12.0 mg/dL for females).
  • Anemic COPD patients exhibited elevated erythropoietin levels (41.8 +/- 25.4 U/L vs 16.3 +/- 2.9 U/L) and increased inflammatory response compared to non-anemic patients.
  • A significant inverse correlation between hemoglobin and erythropoietin was found in anemic COPD patients (r = -0.84, p < 0.01).

Conclusions:

  • Anemic COPD patients demonstrate high erythropoietin levels, suggesting potential erythropoietin resistance.
  • Inflammatory mechanisms, characteristic of anemia of chronic illness, may mediate this erythropoietin resistance in COPD patients.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...